Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Complete Required Lab Monitoring for Anticonvulsant Therapy

Elkhart, Indiana Survey Completed on 02-24-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors identified a deficiency related to failure to ensure a resident’s drug regimen was free from unnecessary drugs by not completing required blood monitoring for an anticonvulsant medication. The resident had multiple diagnoses including dementia, psychosis, anxiety, anemia, atherosclerotic heart disease, severe protein-calorie malnutrition, spondylosis, hypertension, dysphagia, hydronephrosis, hypotension, obstructive and reflux uropathy, and atrophy of the kidney. A quarterly MDS assessment documented that the resident was receiving antianxiety, antidepressant, anticonvulsant, and hypnotic medications. The care plan, initiated in mid-November, identified the resident as being at risk for adverse side effects related to anticonvulsant/antiseizure medication use, with interventions that included obtaining labs as ordered. Physician’s orders showed that Divalproex (Depakote) 125 mg, two capsules twice daily, was started in mid-November, and MARs for November, December, January, and February showed the resident received this medication continuously from mid-November through late February. A physician’s order dated in mid-November directed a one-time blood draw for ammonia and valproic acid levels, but this lab order was discontinued later in November without the tests ever being completed. During interviews, the DON acknowledged that the valproic acid level was intended to be drawn and that no lab results could be found in the chart. The DON further stated that the lab order had been discontinued later in November after being ordered earlier that month. The Regional Director of Clinical Services confirmed that the resident had not had any valproic acid or ammonia levels monitored at all while receiving Divalproex. The facility’s policy on lab and radiology tracking, provided by the DON, required confirmation that each ordered lab was obtained and that any labs not resulted as expected be investigated, but the ordered monitoring labs for this resident were not completed or followed up, leading to the cited deficiency.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙